The potential of 3D printing in drug development and delivery
3D printing will be extensively adopted across various aspects of healthcare in the next ten years.
DSO WP
Ipsen gains global rights to Foreseen Biotech’s FS001 ADC
BARDA and Tiba Biotech link to develop ‘flu therapeutics
Alumis raises $250m in IPO as biotech stock stirs
AI and stable funding environments are catalysts for biotech assets
The lasting impacts of the pandemic on cybersecurity in healthcare
Cyrus Biotechnology to spin out Levitate Bio for biopharma AI
Swiss biotech ecosystem recuperates from global financial instability
